Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation - Related Studies

Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation

This study is currently recruiting participants.

Study NCT00285272. Last updated on October 25, 2007. Information provided by Washington University School of Medicine

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Non-Hodgkins Lymphoma
		Multiple Myeloma

2	Additional conditions recognized in this trial
		Lymphoma
		Lymphoma, Non-Hodgkin
		Neoplasms, Plasma Cell
		Vomiting

3	More general conditions related to this trial
		Blood Protein Disorders
		Cardiovascular Diseases
		Hematologic Diseases
		Hemorrhagic Disorders
		Hemostatic Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Paraproteinemias
		Signs and Symptoms
		Signs and Symptoms, Digestive
		Vascular Diseases

4	Interventions listed in this trial
		aprepitant

5	Additional drug interventions recognized in this trial
		Dexamethasone
		Ondansetron

6	More general drug interventions related to this trial
		Anti-Anxiety Agents
		Anti-Inflammatory Agents
		Antiemetics
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Antipruritics
		Antipsychotic Agents
		Autonomic Agents
		Central Nervous System Agents
		Central Nervous System Depressants
		Dermatologic Agents
		Gastrointestinal Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Antagonists
		Therapeutic Uses
		Tranquilizing Agents

7	Sponsors listed in this trial
		Washington University School of Medicine
		Merck